Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Naji Tabet, Ann Marie Swart et al.|The Lancet|2021Cited by 86
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Sube Banerjee, Martín Knapp et al.|International Psychogeriatrics|2022Cited by 4